These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

843 related items for PubMed ID: 25702254

  • 1. [Hepatitis C: diagnosis, anti-viral therapy, after-care. Hungarian consensus guideline].
    Hunyady B, Gerlei Z, Gervain J, Horváth G, Lengyel G, Pár A, Rókusz L, Szalay F, Telegdy L, Tornai I, Werling K, Makara M.
    Orv Hetil; 2015 Mar 01; 156(9):343-51. PubMed ID: 25702254
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Not Available].
    Hunyady B, Gerlei Z, Gervain J, Horváth G, Lengyel G, Pár A, Péter Z, Rókusz L, Schneider F, Szalay F, Tornai I, Werling K, Makara M.
    Orv Hetil; 2015 Dec 15; 156 Suppl 2():3-24. PubMed ID: 26667111
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Screening, diagnosis, treatment, and follow up of hepatitis C virus related liver disease. National consensus guideline in Hungary from 22 September 2017].
    Hunyady B, Gerlei Z, Gervain J, Horváth G, Lengyel G, Pár A, Péter Z, Rókusz L, Schneider F, Szalay F, Tornai I, Werling K, Makara M.
    Orv Hetil; 2018 Feb 15; 159(Suppl 1):3-23. PubMed ID: 29478339
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Side-effects of pegylated interferon plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection].
    Hunyady B, Kovács B, Battyáni Z.
    Orv Hetil; 2011 Dec 11; 152(50):1997-2009. PubMed ID: 22112373
    [Abstract] [Full Text] [Related]

  • 10. Triple therapy with first generation HCV protease inhibitors: lead-in or no lead-in phase?
    Pascale A, Serfaty L.
    J Hepatol; 2013 Feb 11; 58(2):391-4. PubMed ID: 23063419
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hepatitis C treatment from "response-guided" to "resource-guided" therapy in the transition era from interferon-containing to interferon-free regimens.
    Yu ML.
    J Gastroenterol Hepatol; 2017 Aug 11; 32(8):1436-1442. PubMed ID: 28124463
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of Smoking on Pegylated Interferon alpha 2a and First Generation Protease Inhibitor-based Antiviral Therapy in Naïve Patients Infected with Hepatitis C Virus Genotype 1.
    Zimmermann T, Hueppe D, Mauss S, Buggisch P, Pfeiffer-Vornkahl H, Grimm D, Galle PR, Alshuth U.
    J Gastrointestin Liver Dis; 2016 Mar 11; 25(1):15-24. PubMed ID: 27014750
    [Abstract] [Full Text] [Related]

  • 17. Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues.
    Liu CJ.
    J Gastroenterol Hepatol; 2014 Jan 11; 29(1):26-30. PubMed ID: 24199625
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [New era in the treatment of chronic hepatitis C - novel direct acting antivirals].
    Horváth G, Halász T, Makara M, Hunyady B.
    Orv Hetil; 2015 May 24; 156(21):841-8. PubMed ID: 26038991
    [Abstract] [Full Text] [Related]

  • 20. [Safety and efficacy of telaprevir in patients with HIV and hepatitis C virus coinfection].
    Macías J, Rivero A.
    Enferm Infecc Microbiol Clin; 2013 Jul 24; 31 Suppl 3():33-6. PubMed ID: 24063901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.